Keyphrases
Cancer-related
100%
Phosphodiesterase Type 5 Inhibitors
100%
Statins
100%
Skin Cancer
100%
Tumour Necrosis Factor Inhibitor (TNFi)
100%
Non-melanoma Skin Cancer
100%
Angiotensin Receptor Blockers
100%
Commonly Prescribed Drugs
100%
Malignant Melanoma
42%
Skin Cancer Risk
28%
Area Cover
14%
High Risk
14%
Prescribers
14%
Squamous Cell Carcinoma (SqCC)
14%
Skin Melanoma
14%
Basal Cell Carcinoma
14%
Risk Information
14%
Expert Opinion
14%
3-hydroxy-3-methylglutaryl-coenzyme A
14%
Reductase Inhibitors
14%
MEDLINE
14%
Drug Class
14%
Carcinoma Squamous Cell
14%
Enhanced Education
14%
Top 100
14%
Pharmacology, Toxicology and Pharmaceutical Science
Skin Cancer
100%
Phosphodiesterase V Inhibitor
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Tumor Necrosis Factor Inhibitor
100%
Angiotensin Receptor Antagonist
100%
Melanoma
66%
Non Melanoma Skin Cancer
66%
Melanoma Skin Cancer
50%
Squamous Cell Carcinoma
16%
Basal Cell Carcinoma
16%
HMG-CoA
16%
Oxidoreductase
16%
Medicine and Dentistry
Angiotensin Receptor Antagonist
100%
TNF Inhibitor
100%
Statin
100%
Phosphodiesterase V Inhibitor
100%
Skin Cancer
100%
Melanoma
66%
Non Melanoma Skin Cancer
66%
Cancer Risk
33%
Oxidoreductase
16%
Squamous Cell Carcinoma
16%
Basal-Cell Carcinoma
16%
HMG-CoA
16%
Cancer
16%